BRIDGEBIO PHARMA INC. - COMMON STOCK
25.23
04-10月-24 15:59:59
15 分の遅延
株式
-0.40
-1.56%
本日の幅
25.12 - 26.05
ISIN
N/A
ソース
NASDAQ
-
03 6 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
14 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
13 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
02 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 4 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 3 2024 23:53:56 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 3 2024 16:17:36 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 3 2024 02:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 2 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
07 2 2024 07:34:22 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 2 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
18 1 2024 07:00:00 提供 Nasdaq GlobeNewswire